Chuck Grassley actually said...

The Cantwell-Grassley PBM Transparency Act directs the FTC to end well-known and documented PBM practices that drive up consumer costs.

I worked at the FTC, and I can tell you that with the Agency's overreach and activism, which will no doubt be difficult to sustain in court,...

Today, three PBMs control 80 percent of the market. We must do something about powerful middlemen to lower drug costs for consumers.

Our investigation found that the PBM scheme encourages drug makers to spike the drug's list price.